A comparative study to determine the safety and efficacy of Autologous Human Platelet Lysate (HPL)for Treatment of Androgenetic Alopecia (AGA)
Phase 1
Completed
- Conditions
- Health Condition 1: null- Androgenetic Alopecia
- Registration Number
- CTRI/2012/04/002614
- Lead Sponsor
- Kasiak Research Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1.Male subjects, aged between 18 to 50 years (both inclusive) and in general good health
2.Subjects willing to refrain from other AGA treatments during the entire study duration
3.Subjects who are willing to give informed consent and adhere to the study protocol.
Exclusion Criteria
1.Subjects aged <18 or > 50 years
2. Subjects with dermatological disorder of scalp that might interfere with study evaluation
3.Subjects on Anti-coagulant therapy
4.Subjects with clinically significant medical or psychiatric disease as determined by the investigator.
5. Subjects with dermatological disorder of scalp that might interfere with study evaluation
6. Subjects unwilling to or unable to comply with the study protocol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method